- LanzaTech and BRIGHT (DTU) signed a multi-year agreement to design and install a next-generation C1 biofoundry at DTU
- The partnership runs until April 2028
- The biofoundry targets conversion of CO, CO₂ and methane into fuels, chemicals and materials
- LanzaTech will provide tailored methods, a non-exclusive IP license and a customized anaerobic, gas-handling biofoundry with validated high-throughput workflows
Overview
BRIGHT (DTU) and LanzaTech signed a multi-year agreement to design and install a next-generation C1 biofoundry at DTU; the partnership runs until April 2028 and targets conversion of CO, CO₂ and methane into fuels, chemicals and materials.
Technology and capabilities
The biofoundry will deploy gas fermentation with engineered microbes and require automation, AI, robotics, specialized gas-handling and high-throughput strain-development tools to accelerate Design–Build–Test–Learn cycles, reduce innovation risk, and enable safe work with non-model anaerobic organisms and flammable or toxic gases.
LanzaTech scope and contributions
LanzaTech will develop tailored methods and workflows for BRIGHT, provide a non‑exclusive license to relevant biofoundry IP, and design and install a customized C1 facility with anaerobic and validated gas‑handling workflows, leveraging its 15+ years of gas‑fermentation R&D and prior dedicated biofoundry experience.
Strategic impact
The installed C1 biofoundry will create a shared R&D platform for researchers and partners across Denmark and Europe to speed carbon‑to‑value biotechnology development and enable scale‑up routes, while allowing LanzaTech to consolidate biotechnology expertise and focus other teams on commercial SAF and biorefining projects.
